Modulight Biotherapeutics, developer of novel optogenetic platform for the treatment of neurological disorders, announced today the closing of its Seed funding round raising $12.2 million. The Seed ...

Experience sharper focus, stronger memory, and peak cognitive performance with Neurocept—an advanced brain support supplement ...

A study found 26 DNA regions tied to fibromyalgia, showing the disorder originates in the brain’s pain circuits, not in muscles.

Queen’s researcher Dr. Sébastien Talbot, whose recent Nature paper examines the connection between nerves and tumour response, is advancing the field of cancer neuroscience.